ENGLISH
|
JAPANESE
|
CONNECT WITH US:
Home
About
Contact
Log in
*
Home
Press release
Aug 31, 2022 11:00 JST
Source:
Apeiron Bioenergy
Apeiron Bioenergy closes equity investment from Mitsui Chemicals, poised to capture exponential growth in bioenergy market with Pan-Asian presence
- Mitsui Chemicals has invested to support Apeiron's Pan-Asia expansion
- Strategic partnership with Mitsui Chemicals will enhance Apeiron's regional scalability and commitment to achieving net-zero emissions
SINGAPORE, Aug 31, 2022 - (ACN Newswire) - Apeiron Bioenergy has successfully closed an equity financing round from Mitsui Chemicals. The funds will support Apeiron to increase its collection capacity for waste-based feedstocks across Asian markets and position the company for exponential growth amidst growing demand for renewable feedstock for advanced biofuels such as sustainable aviation fuel (SAF).
From left: Chris Chen, Managing Director, Apeiron Bioenergy; Tadashi Yoshino, Representative Director, Mitsui Chemicals
According to the International Energy Agency , global demand for renewable diesel is set to more than double, or by 11 billion litres, over the next five years. The demand mainly stems from government regulations in the US and the EU as established in the decarbonisation targets by COP26. However, the planned capacity is set to outpace domestic feedstock supply significantly, and production must keep up with the climate emergency - where will the additional feedstock come from?
A leading integrated player and solutions provider in the bioenergy space, Apeiron Bioenergy, collects and processes a range of renewable feedstocks including used cooking oil (UCO) and palm oil mill effluent (POME) acts as a critical exporter across an ever-expanding Asian market. Over the past 15 years, Apeiron Bioenergy has built its presence in over 10 countries and collected more than 500 million litres of UCO between 2017-2021, offsetting an estimated 1.5 million tonnes of carbon emissions.
"Zero Carbon emissions is one of our strategic targets by 2050. As one of Japan's leading chemical companies, our investment in Apeiron is our way of contributing to solving the world's future environmental issues," said Tadashi Yoshino, Representative Director, Managing Executive Officer, Mitsui Chemicals. "Apeiron Bioenergy has a proven track record of aggregating renewable feedstock and streamlining the supply chain across Asia. We are delighted to invest in the company as it aligns with our sustainability goals."
Apeiron Bioenergy's access to diversified sources and networks of feedstock and relationships with downstream customers means it is in an excellent position to access and supply downstream by-products for Mitsui Chemicals to help achieve its net zero targets.
With Mitsui Chemicals serving as a strategic investor, Apeiron Bioenergy will be well-positioned to meet the substantial rise in demand for biofuels by ramping up its capacity of collection points and processing facilities through both organic and inorganic growth. The company is actively seeking to acquire or collaborate with local collectors of sustainable feedstocks in the Asian markets.
"Tackling supply chain issues in Bioenergy across Asia requires a community-focused, collaborative approach - our seasoned management team has proven that we can resolve supply chain inefficiencies with our multicultural and multi-jurisdictional strategy," said Chris Chen, Managing Director of Apeiron Bioenergy. "We will be ramping up our collection capability, collaborating closely with our downstream partners to resolve the wider sustainability problem of reducing carbon emissions across the land, sea and air transportation spaces."
For all media queries, please contact:
Chi-an Chang
Financial PR
T: +65-6438-2990
E:
chi-an@financialpr.com.sg
Source: Apeiron Bioenergy
Sectors: Energy, Alternatives, Alternative Energy, Oil & Gas
Copyright ©2024 ACN Newswire. All rights reserved. A division of Asia Corporate News Network.
Latest Release
TOYOTA GAZOO Racing FULLY PREPARED FOR DAKAR 2025
Nov 26, 2024 17:55 JST
Eisai Signs Research Collaboration Agreement with The National Center of Neurology and Psychiatry to Initiate Apolipoprotein E Genetic Testing in the "AD-DMT Registry" in Japan
Nov 26, 2024 15:50 JST
Fujitsu develops Policy Twin, a new digital twin technology to maximize effectiveness of local government policies for solving societal issues
Nov 26, 2024 10:51 JST
TOYOTA GAZOO Racing reinforces WRC line-up with youth and experience for 2025
Nov 25, 2024 17:10 JST
Toyota Submits Progress Report on Recurrence Prevention Measures
Nov 25, 2024 15:43 JST
MHI Thermal Systems Receives Order from Aisan Industry for Aquifer Thermal Energy Storage System for Its New Anjo Plant
Nov 25, 2024 14:18 JST
Oracle Red Bull Racing Driver Max Verstappen Wins Fourth Consecutive F1 Drivers' World Championship
Nov 25, 2024 11:55 JST
Kaplan Fox & Kilsheimer LLP Alerts Investors to a Securities Class Action Against Humacyte, Inc. (HUMA) - Deadline is January 17, 2025
Nov 22, 2024 11:00 JST
NaaS Q3 2024 Recap: Strategic Shifts and Tech Innovations for Growth
Nov 21, 2024 22:59 JST
Honda Unveils Demonstration Production Line for All-Solid-State Batteries Located in Sakura City, Tochigi Prefecture, Japan
Nov 21, 2024 15:35 JST
Deadline to Lead in Securities Fraud Lawsuit Against Humacyte, Inc. (HUMA) is January 17, 2025 - Contact Kaplan Fox & Kilsheimer LLP
Nov 21, 2024 09:00 JST
ALL Study Groups Using DehydraTECH Processing Outperform Rybelsus(R) in Body Weight Control in Lexaria's 12-Week GLP-1, Diabetes Animal Study
Nov 20, 2024 23:05 JST
Start of Demonstration Test of Two-Phase Direct-to-Chip Cooling in the Air-Cooled Data Center
Nov 20, 2024 15:30 JST
Rozebalamin for Injection 25mg (Mecobalamin) for Amyotrophic Lateral Sclerosis Launched in Japan
Nov 20, 2024 11:51 JST
Anticancer Agent "TASFYGO Tablets 35mg" (Tasurgratinib Succinate) Launches in Japan for Biliary Tract Cancer with FGFR2 Gene Fusion or Rearrangements
Nov 20, 2024 10:24 JST
Kingsoft Announces 2024 Third Quarter Results
Nov 19, 2024 18:54 JST
NTT and Olympus Joint Demonstration Shows IOWN APN's Low-latency Capability Can Be Used for Real-time Diagnosis and Treatment on a Remote Server to Realize World's First Cloud Endoscopy System
Nov 19, 2024 15:30 JST
Supercomputer Fugaku retains first place worldwide in HPCG and Graph500 rankings
Nov 19, 2024 09:02 JST
CleverTap Recognized as a Strong Performer in Cross-Channel Marketing Hubs, Q4 2024 Report
Nov 18, 2024 23:30 JST
World's First Successful Trial of Quantum Tokens Created Using Quantum Technology
Nov 18, 2024 17:29 JST
More Latest Release >>
Related Release
Apeiron Bioenergy Raises S$50 million through an Investment Grade Green Bond, the First Bioenergy-Focused SGD Bond Issuance in Asia
June 26 2023 12:00 JST
Apeiron Bioenergy secures equity investment from Proterra Investment Partners Asia to solidify upstream capabilities
October 06 2022 13:00 JST
More Press release >>